Moors & Cabot, Inc. Q2 2017 Filing

Filed August 15, 2017

Portfolio Value

$601.8B

Holdings

509

Report Date

Q2 2017

Filing Type

13F-HR

All Holdings (509 positions)

#StockSharesValue% PortfolioType
501
LADENBURG THALMAN FIN SVCS I
13,000$30.0M0.00%
502
CASI PHARMACEUTICALS INC
26,053$27.0M0.00%
503
DXLGDESTINATION XL GROUP INC
10,000$24.0M0.00%
504
RAIT FINANCIAL TRUST
10,865$23.0M0.00%
505
BIOPHARMX CORP
40,000$19.0M0.00%
506
GSTEURGASTAR EXPL INC NEW
20,000$18.0M0.00%
507
FRONTIER COMMUNICATIONS CORP
11,372$12.0M0.00%
508
SNYSANOFI
16,000$6.0M0.00%
509
SDRLSEADRILL LIMITED
15,400$5.0M0.00%
PreviousPage 6 of 6